Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Selenium and Reduced Total Triiodothyronine

Safety in these studies

Overall tolerabilityNo significant differenceOR 0.89 [CI 0.46 to 1.75]
Adverse effects were comparable between the intervention and control groups (OR 0.89 [CI 0.46 to 1.75]; 16 cohorts; 1339 participants; I²=0%).
from: Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and M

1 of 1 paper

Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- 2024-03
- Meta-Analysis · n = 2,358
- Thyroid : official journal of the American Thyroid Association 34(3)
- - Valentina V Huwiler
  - Stephanie Maissen-Abgottspon
  - Zeno Stanga
  - Stefan Mühlebach
  - Roman Trepp
  - Lia Bally
  - Arjola Bano
- PubMed: 38243784
- DOI: 10.1089/thy.2023.0556
11 Insights on
- Reduced Total Triiodothyronine
- High evidence
- Clinical
No significant changes were observed in T3
Effect
Neutral
Effect size
Small
Significant
No